Bartlett & Co. LLC
- SEC CIK
- 0001550075
- Latest filing
- Jan 8, 2024
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Bartlett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q4 2023 holdings
- Shares (Q4 2023)
- 200
- Value
- $82.0K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 200 | $82.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 200 | $70.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 200 | $70.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 200 | $63.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 200 | $58.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 200 | $58.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 200 | $56.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 200 | $52.0K | <0.1% | +200 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −4−100.0% | Sold out | Holders |
| Q2 2021 | 4 | $1.00K | <0.1% | −50−92.6% | Reduced | Holders |
| Q1 2021 | 54 | $12.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.